As of 2025-03-25, the EV/EBITDA ratio of Guardant Health Inc (GH) is -13.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 5,768.65 mil USD. GH's TTM EBITDA according to its financial statements is -416.91 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 6.0x - 11.3x | 8.6x |
| Forward P/E multiples | 7.2x - 17.4x | 12.3x |
| Fair Price | (24.19) - (38.04) | (35.30) |
| Upside | -151.7% - -181.4% | -175.5% |
| Date | EV/EBITDA |